5 completed. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 5 |
Follow opicapone: new trials by email Literature Review of opicapone trials Research Report on opicapone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs. Opicapone, L-DOPA/DDCI - Parkinson Disease | Phase 4 | Completed | Bial - Portela C S.A. | 106 | 2021-11-29 | 2025-03-12 |
| A Study to Evaluate the add-on Efficacy and Safety of Opicapone 50 mg or an Extra Dose of L-DOPA 100 mg for the Treatment of Wearing-off in Patients With PD Ongentys 50mg, Madopar Tab. 125 or Perkin Tab. 25-100mg - Parkinson Disease | Phase 4 | Completed | SK Chemicals Co., Ltd. | 169 | 2021-06-17 | 2023-06-01 |
| OpicApone Sleep dISorder Opicapone - Parkinson Disease | Phase 4 | Completed | Bial - Portela C S.A. | 22 | 2021-06-09 | 2025-03-12 |
| OpiCapone Effect on Motor Fluctuations and pAiN Opicapone 50 mg, Placebo - Parkinson Disease | Phase 4 | Completed | Bial - Portela C S.A. | 144 | 2021-02-25 | 2025-03-28 |
| Efficacy and Safety of Opicapone in Clinical Practice BIA 9-1067, levodopa/dopa decarboxylase inhibitor - Parkinson's Disease With Wearing-off Motor Fluctuations | Phase 4 | Completed | Bial - Portela C S.A. | 518 | 2016-11-23 | 2018-10-15 |
Bial - Portela C S.A. (4) · SK Chemicals Co., Ltd. (1)
Germany (2) · Portugal (2) · United Kingdom (2) · Italy (1) · South Korea (1) · Spain (1)
Kallol Ray Chaudhuri, MD, DSc (1)
2016 (1)